Clinical trials
Phase 3 trials in India with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 8 |
| 2009 | 6 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 6 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 85 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Post Graduate Institute of Medical Education and Research, Chandigarh | 10 |
| All India Institute of Medical Sciences | 9 |
| Tata Memorial Hospital | 8 |
| Asian Institute of Gastroenterology, India | 5 |
| Bharat Biotech International Limited | 5 |
| Tuberculosis Research Centre, India | 3 |
| Cadila Pharnmaceuticals | 2 |
| Indian Council of Medical Research | 2 |
| International Atomic Energy Agency | 2 |
| National Cancer Centre, Singapore | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 4 |
| COVID-19 | 4 |
| Uterine Cervical Neoplasms | 4 |
| Colitis, Ulcerative | 3 |
| Tuberculosis | 3 |
| Asthma | 2 |
| Cardiovascular Diseases | 2 |
| Cholera | 2 |
| Diabetes Mellitus | 2 |
| Leukemia, Myeloid, Acute | 2 |
Trials
Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.